Why the study?
Evidence was lacking on combining SYNTAX score II and erythrocyte sedimentation rate to assess long-term prognosis in STEMI patients with multivessel disease.
Does the addition of erythrocyte sedimentation rate (ESR) to the SYNTAX score II (SSII) improve the prediction of long-term MACE in STEMI patients with multivessel disease?
Population
483 STEMI and multivessel disease subjects receiving primary percutaneous coronary intervention
Comparison
Prognostic model containing SSII and ESR vs SSII alone
Design
Retrospective cohort study
Follow-up
Up to 52 months
Authors
Loading...
May enhance MACE risk stratification when added to SSII in STEMI; hypothesis-generating and requires prospective validation.
Does the addition of erythrocyte sedimentation rate (ESR) to the SYNTAX score II (SSII) improve the prediction of long-term MACE in STEMI patients with multivessel disease?
Adding erythrocyte sedimentation rate to the SYNTAX score II significantly improves long-term prognostic prediction for MACE in STEMI patients with multivessel disease.
Li et al. (2020) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: